Tylenol, Theraflu, NyQuil, and DayQuil
Allegations: Falsely marketing that phenylephrine products treat nasal congestion
Children’s Dimetapp, DayQuil, Mucinex, Mucinex Children’s, and Sudafed
Case Name (Date)
Wilson et al. v. Johnson & Johnson Consumer, Inc. et al.
23-cv-21276, D.N.J.
(Oct. 2023)
Product/Service
Children’s Dimetapp, DayQuil, Mucinex, Mucinex Children’s, and Sudafed
Allegations
Falsely marketing that phenylephrine products treat nasal congestion when phenylephrine is not an effective decongestant when taken orally
Status
Pending
Class-Action Tracker
NyQuil, Tylenol, Sudafed, Mucinex, and Several Store Brands
Allegations: Falsely marketing that medicines treat nasal congestion
Advil, Tylenol, DayQuil, NyQuil, TheraFlu, Sudafed, and Other Cold and Flu Medicines
Allegations: Falsely marketing that medicines are decongestants
Cold and Flu Medicines
Allegations: Falsely marketing the products treat nasal congestion
Several Brands of Cold and Flu Medicines
Allegations: Falsely marketing that phenylephrine products treat congestion and other cold and flu symptoms
Alka-Seltzer, Theraflu, Rite Aid, and Walgreens Cold and Flu Medicines
Allegations: Falsely marketing that medicines treat nasal congestion
DayQuil, NyQuil, and Theraflu
Allegations: Falsely marketing that medicines treat nasal congestion
Emergen-C Raspberry Daily Immune Support Dietary Supplement
Allegations: Misleadingly marketing drink mixes using the phrase “Natural fruit flavor” and images of raspberries when they contain artificial flavoring ingredients
TheraFlu Emergen-C and TheraFlu Multi-Symptom Severe Cold
Allegations: Misleadingly marketing products as if they treat symptoms of coughs and colds
Benefiber Prebiotic Powders
Allegations: False natural claims
Benefiber Fiber Supplements
Allegations: False natural claims
Benefiber Prebiotic Powder
Benefiber Prebiotic Supplement
The Latest
9 Earth-Friendly Claims to Watch Out for This Earth Day
Green marketing claims you should think twice about.
Advertising of Supplement Targeting Seniors Questioned
TINA.org Joins with AARP in Objecting to Move Free Class-Action Settlement MADISON, Conn., March 12, 2015 — More than 46 million people suffer from arthritis, many of them elderly, and…
Lawsuits: Glucosamine’s Promised Relief Mostly Marketing Hype
Consumers report adverse reactions.
Swiffer Swept up in Broom-Bashing Claims
Self-regulatory body calls supporting evidence behind superiority claims “materially flawed.”
Cold Products Pay Millions for Misleading Consumers
Unproven cold prevention and treatment claims are nothing to sneeze at.